Arginine Supplementation and Immune System Function in Cancer and Viral Infections
Low arginine levels may allow cancer cells and viruses to slip past the immune system by reducing production of a crucial cellular warning protein. In mice, arginine-rich diets led to fewer colon tumors and milder viral
Research has focused on the role of arginine in the immune system, particularly in relation to cancer and viral infections. In mice, low levels of arginine were found to impair the production of a crucial cellular warning protein, allowing cancer cells and viruses to evade the immune system. As a result, researchers have investigated the potential benefits of arginine supplementation in cancer treatment and viral management. In a mouse model, arginine-rich diets led to a significant reduction in colon tumors and milder viral infections, suggesting a potential therapeutic application. However, further research is needed to confirm these findings in humans and to fully understand the mechanisms underlying this relationship. Additionally, the optimal dosage and duration of arginine supplementation for cancer treatment and viral management remain unknown. The current study's findings highlight the importance of arginine in immune system function and provide a starting point for further investigation into its potential therapeutic applications. Further research is needed to explore the efficacy and safety of arginine supplementation in humans, particularly in the context of cancer treatment and viral management.